Lomustine

Lomustine BModesto capsules, hard 40 mg

Capsule, hardNetherlandsAuthorisedAuthorised 28 May 2020

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Lomustine

Lomustine BModesto capsules, hard 40 mg

Capsule, hardNetherlandsAuthorisedAuthorised 28 May 2020

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Lomustine
Dosage form: Capsule, hard
Route: Oraal gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 28 May 2020
Registration: 126791//07439
Marketing authorisation holder: BModesto B.V.
ATC code: L01AD02
Group: Antineoplastic and immunomodulating agents
Procedure: National (RVG)
Supply: Uitsluitend recept